Clinical and Microbiological Characteristics of Bloodstream Infections due to CRKP.

IF 0.7 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY
Li-Li Fang, Xiao-Ying Lan, Zhi-Meng Li, Jian-Ping Sun, Hai-Yue Liu, Guo-Lin Hong, Xian-Ming Liang
{"title":"Clinical and Microbiological Characteristics of Bloodstream Infections due to CRKP.","authors":"Li-Li Fang, Xiao-Ying Lan, Zhi-Meng Li, Jian-Ping Sun, Hai-Yue Liu, Guo-Lin Hong, Xian-Ming Liang","doi":"10.7754/Clin.Lab.2025.250860","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKP) often result in high mortality rates. This study aimed to explore the local epidemiology and risk factors of CRKP bloodstream infections, characterize the resistance and virulence genes of CRKP isolates in this region of China, and identify the circulating hypervirulent Klebsiella pneumoniae strains locally.</p><p><strong>Methods: </strong>In a case-controlled retrospective study, we examined the prevalence, patient background, and risk factors for CRKP BSIs.</p><p><strong>Results: </strong>The overall CRKP BSI incidence was 2.2 (54/2,420,826) per 100,000 patient-days. Acute operation (p = 0.012), being a resident in a long-term-care facility (p = 0.019), transfer to ICU within 30 days (p = 0.014), pulmonary diseases (p = 0.022), renal diseases (p = 0.004), liver diseases (p = 0.008), abdominal infections (p = 0.005), gastric tube (p = 0.011), quinolone use (p = 0.029), carbapenem use (p = 0.001), and antifungal agent use prior to culture within 30 days (p = 0.001) were risk factors for CRKP BSIs. In total, 88.9% (48/54) isolates were detected with KPC carbapenemase, followed by NDM carbapenemase at 7.4% (4/54). YcfM, wabG, and entB were present in all strains. The following four virulence genes had a positivity rate of over 90%: fimH (98.15%), mrkD (96.30%), uge (92.60%), and kpn (92.60%).</p><p><strong>Conclusions: </strong>Acute operation, being a resident in a long-term-care facility, transfer to ICU within 30 days, pulmonary diseases, renal diseases, liver diseases, abdominal infections, gastric tube, quinolone use, carbapenem use, and antifungal agent use prior to culture within 30 days were risk factors for CRKP BSIs. KPC carbapenemase ranked first in isolates of CRKP BSIs. Virulence genes were widely present.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"72 9","pages":"1892-1900"},"PeriodicalIF":0.7000,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical laboratory","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7754/Clin.Lab.2025.250860","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKP) often result in high mortality rates. This study aimed to explore the local epidemiology and risk factors of CRKP bloodstream infections, characterize the resistance and virulence genes of CRKP isolates in this region of China, and identify the circulating hypervirulent Klebsiella pneumoniae strains locally.

Methods: In a case-controlled retrospective study, we examined the prevalence, patient background, and risk factors for CRKP BSIs.

Results: The overall CRKP BSI incidence was 2.2 (54/2,420,826) per 100,000 patient-days. Acute operation (p = 0.012), being a resident in a long-term-care facility (p = 0.019), transfer to ICU within 30 days (p = 0.014), pulmonary diseases (p = 0.022), renal diseases (p = 0.004), liver diseases (p = 0.008), abdominal infections (p = 0.005), gastric tube (p = 0.011), quinolone use (p = 0.029), carbapenem use (p = 0.001), and antifungal agent use prior to culture within 30 days (p = 0.001) were risk factors for CRKP BSIs. In total, 88.9% (48/54) isolates were detected with KPC carbapenemase, followed by NDM carbapenemase at 7.4% (4/54). YcfM, wabG, and entB were present in all strains. The following four virulence genes had a positivity rate of over 90%: fimH (98.15%), mrkD (96.30%), uge (92.60%), and kpn (92.60%).

Conclusions: Acute operation, being a resident in a long-term-care facility, transfer to ICU within 30 days, pulmonary diseases, renal diseases, liver diseases, abdominal infections, gastric tube, quinolone use, carbapenem use, and antifungal agent use prior to culture within 30 days were risk factors for CRKP BSIs. KPC carbapenemase ranked first in isolates of CRKP BSIs. Virulence genes were widely present.

CRKP血流感染的临床和微生物学特征。
背景:碳青霉烯耐药肺炎克雷伯菌(CRKP)引起的血流感染通常导致高死亡率。本研究旨在探讨CRKP血流感染的当地流行病学和危险因素,对中国该地区CRKP分离株的耐药和毒力基因进行表征,并确定当地流行的高毒力肺炎克雷伯菌菌株。方法:在一项病例对照的回顾性研究中,我们检查了CRKP BSIs的患病率、患者背景和危险因素。结果:总体CRKP BSI发生率为2.2(54/2,420,826)/ 100,000患者日。急性手术(p = 0.012)、长期护理机构住院(p = 0.019)、30天内转入ICU (p = 0.014)、肺部疾病(p = 0.022)、肾脏疾病(p = 0.004)、肝脏疾病(p = 0.008)、腹部感染(p = 0.005)、胃管(p = 0.011)、喹诺酮类药物使用(p = 0.029)、碳青霉烯类药物使用(p = 0.001)、30天内培养前使用抗真菌药物(p = 0.001)是CRKP bsi的危险因素。KPC碳青霉烯酶检测阳性率为88.9% (48/54),NDM碳青霉烯酶检测阳性率为7.4%(4/54)。所有菌株均含有YcfM、wabG和entB。阳性检出率在90%以上的毒力基因为:fimH(98.15%)、mrkD(96.30%)、uge(92.60%)和kpn(92.60%)。结论:急性手术、长期护理机构住院、30天内转入ICU、肺部疾病、肾脏疾病、肝脏疾病、腹部感染、胃管、喹诺酮类药物使用、碳青霉烯类药物使用、培养前30天内使用抗真菌药物是发生CRKP性脑损伤的危险因素。在分离的CRKP BSIs中,KPC碳青霉烯酶排在首位。毒力基因广泛存在。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical laboratory
Clinical laboratory 医学-医学实验技术
CiteScore
1.50
自引率
0.00%
发文量
494
审稿时长
3 months
期刊介绍: Clinical Laboratory is an international fully peer-reviewed journal covering all aspects of laboratory medicine and transfusion medicine. In addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies. The journal publishes original articles, review articles, posters, short reports, case studies and letters to the editor dealing with 1) the scientific background, implementation and diagnostic significance of laboratory methods employed in hospitals, blood banks and physicians'' offices and with 2) scientific, administrative and clinical aspects of transfusion medicine and 3) in addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书